Hangzhou Tigermed Consulting Co., Ltd.
3347.HK
Price:
$29.2
Market Cap:
$32.67B
Hangzhou Tigermed Consulting Co., Ltd. provides contract research organization services in the People's Republic of China and internationally. It operates in Clinical Trial Solutions, and Clinical-related and Laboratory Services segments. The company offers regulatory submission and approval, medical translation, and good manufacturing practice (GMP) consulting services; and clinical services in the areas of medical science, early clinical and late phase development, medical monitoring, project management, patient recruitment, and quality management system. It also provides biometrics services comprising data management, biostatistics, and statistical programming; and integrated technology s...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2020-08-07
Stock Exchange
HKSE
Ticker
3347.HK
PE Ratio
[69.52]
ROE
[1.62%]
Current Ratio
[1.62]
Dividend Yield
[1.19%]
Enterprise Value
[34.22B]
Dividend History
The PE Ratio as of May 2025 (TTM) for Hangzhou Tigermed Consulting Co., Ltd. (3347.HK) is 69.52
According to Hangzhou Tigermed Consulting Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 69.52. This represents a change of 122.12% compared to the average of 31.30 of the last 4 quarters.
Hangzhou Tigermed Consulting Co., Ltd. (3347.HK) Historical PE Ratio (quarterly & annually)
How has 3347.HK PE Ratio performed in the past?
The mean historical PE Ratio of Hangzhou Tigermed Consulting Co., Ltd. over the last ten years is 62.69. The current 69.52 PE Ratio has changed 10.99% with respect to the historical average. Over the past ten years (40 quarters), 3347.HK's PE Ratio was at its highest in in the September 2016 quarter at 175.60. The PE Ratio was at its lowest in in the December 2024 quarter at -28.83.
Average
62.69
Median
57.03
Minimum
22.66
Maximum
116.21
Hangzhou Tigermed Consulting Co., Ltd. (3347.HK) PE Ratio by Quarter and Year
Discovering the peaks and valleys of Hangzhou Tigermed Consulting Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 412.90%
Maximum Annual PE Ratio = 116.21
Minimum Annual Increase = -49.84%
Minimum Annual PE Ratio = 22.66
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | 116.21 | 412.90% |
| 2023 | 22.66 | -49.84% |
| 2022 | 45.17 | 17.00% |
| 2021 | 38.61 | -47.44% |
| 2020 | 73.46 | 31.45% |
| 2019 | 55.88 | 34.74% |
| 2018 | 41.48 | -28.71% |
| 2017 | 58.18 | -35.40% |
| 2016 | 90.05 | 5.67% |
| 2015 | 85.22 | 63.61% |
Hangzhou Tigermed Consulting Co., Ltd. (3347.HK) Average PE Ratio
How has 3347.HK PE Ratio performed in the past?
The current PE Ratio of Hangzhou Tigermed Consulting Co., Ltd. (3347.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
61.35
5-year avg
59.22
10-year avg
62.69
Hangzhou Tigermed Consulting Co., Ltd. (3347.HK) PE Ratio vs. Peers
How is 3347.HK’s PE Ratio compared to its peers?
Hangzhou Tigermed Consulting Co., Ltd.’s PE Ratio is greater than Pharmaron Beijing Co., Ltd. (21.87), greater than WuXi AppTec Co., Ltd. (15.80), greater than Akeso, Inc. (-127.06), greater than Hygeia Healthcare Holdings Co., Limited (15.19), greater than Innovent Biologics, Inc. (-946.45),
| Company | PE Ratio | Market cap |
|---|---|---|
| 21.87 | $41.35B | |
| 15.80 | $191.47B | |
| -127.06 | $74.54B | |
| 15.19 | $9.57B | |
| -946.45 | $96.66B |
Build a custom stock screener for Hangzhou Tigermed Consulting Co., Ltd. (3347.HK) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hangzhou Tigermed Consulting Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Hangzhou Tigermed Consulting Co., Ltd. (3347.HK) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Hangzhou Tigermed Consulting Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the PE Ratio?
How can you use the PE Ratio?
What is Hangzhou Tigermed Consulting Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for Hangzhou Tigermed Consulting Co., Ltd. (3347.HK)?
What is the highest PE Ratio for Hangzhou Tigermed Consulting Co., Ltd. (3347.HK)?
What is the 3-year average PE Ratio for Hangzhou Tigermed Consulting Co., Ltd. (3347.HK)?
What is the 5-year average PE Ratio for Hangzhou Tigermed Consulting Co., Ltd. (3347.HK)?
How does the current PE Ratio for Hangzhou Tigermed Consulting Co., Ltd. (3347.HK) compare to its historical average?